Forum for Science, Industry and Business

Sponsored by:     3M 
Search our Site:

 

UCSD Bioengineers Develop First Computer Model that Predicts Disease Variant Based on Genetic Defect

14.11.2002


Bioengineers have for the first time used a computer model to relate specific genetic mutations to exact variations of a disease. This is the first model-based system for predicting phenotype (function of the cell or organism) based on genotype (an individual’s DNA).


Bernhard Palsson, Professor, Bioengineering



In the study, published in Genome Research (Vol. 12, Issue 11, 1687-1692, November 2002, article link), Bernhard Palsson and his team at UCSD’s Jacobs School of Engineering reviewed genetic information from patients who have an enzyme deficiency that causes hemolytic anemia. Physicians have recorded some 150 DNA sequence variations that could be involved in this type of anemia. By inserting the specific DNA sequences into a computer model for red blood cell metabolism, Palsson accurately predicted which mutations would result in chronic hemolytic anemia and which would cause a less severe version of the disease.

“Eventually, there could be a kind of databank of specific genetic mutations that cause precise disease variants,” says Palsson. “Some mutations will be severe, others benign. And every variation of a disease could be treated differently. This could be incredibly useful for drug development and will aid physicians in creating effective treatment plans for individuals.” A person’s risk of getting a disease is often influenced by a permutation in a single base pair in their genome, called a single nucleotide polymorphism (SNP). And for any one type of cancer such as breast cancer, there may be as much as a dozen variations of the disease. Now that the human genome has been mapped, biotechnology companies and scientists are feverishly developing processes to uncover SNPs that are related to variations of diseases such as cancer, heart disease and a host of inherited disorders.


Until now, most approaches have relied on statistical correlations between reported mutations and occurrences of disease variants.

Palsson’s technique actually defines the mechanism by which a genetic defect causes a disease. He was able to make this mathematical calculation by building a computer model that is based on the well-known metabolism in the human red blood cell.

“The model is like the wiring diagram or design drawings for the cell,” says Palsson. “It incorporates all the genes in the cell, the products of each, and the interwoven process of how those products interact to produce cellular functions. Once we have this computer (now called in silico) model, it is in principle a fairly straightforward process to alter a specific DNA sequence, run a simulation on the program, and receive information back about how the defect impacts the cell’s function.”

Palsson notes that his model is based on 30 years of chemistry and biology research about metabolism in the red blood cell, which is one of the human body’s simplest and most well-understood cell types.

“Building in silico models is a complex process requiring hard-to-find expertise, and it will take a few years before these kinds of models will become common place for diagnosis, management of disease, and development of therapeutics,” says Palsson. “It has become a widely held expectation by an increasing number of scientists that in silico models of human disease processes will significantly impact future delivery of health care. Our research is significant in that we are demonstrating the proof of concept for the first time.”

UCSD has formed a spin-off company, called Genomatica, to bring Palsson’s in silico modeling technologies into commercial use.

Denine Hagen | EurekAlert!
Further information:
http://www.genome.org/cgi/content/full/12/11/1687
http://gcrg.ucsd.edu/personnel/palsson.htm
http://www.genomatica.com/index1.html

More articles from Health and Medicine:

nachricht Study tracks inner workings of the brain with new biosensor
16.08.2018 | Rheinische Friedrich-Wilhelms-Universität Bonn

nachricht Foods of the future
15.08.2018 | Georg-August-Universität Göttingen

All articles from Health and Medicine >>>

The most recent press releases about innovation >>>

Die letzten 5 Focus-News des innovations-reports im Überblick:

Im Focus: Color effects from transparent 3D-printed nanostructures

New design tool automatically creates nanostructure 3D-print templates for user-given colors
Scientists present work at prestigious SIGGRAPH conference

Most of the objects we see are colored by pigments, but using pigments has disadvantages: such colors can fade, industrial pigments are often toxic, and...

Im Focus: Unraveling the nature of 'whistlers' from space in the lab

A new study sheds light on how ultralow frequency radio waves and plasmas interact

Scientists at the University of California, Los Angeles present new research on a curious cosmic phenomenon known as "whistlers" -- very low frequency packets...

Im Focus: New interactive machine learning tool makes car designs more aerodynamic

Scientists develop first tool to use machine learning methods to compute flow around interactively designable 3D objects. Tool will be presented at this year’s prestigious SIGGRAPH conference.

When engineers or designers want to test the aerodynamic properties of the newly designed shape of a car, airplane, or other object, they would normally model...

Im Focus: Robots as 'pump attendants': TU Graz develops robot-controlled rapid charging system for e-vehicles

Researchers from TU Graz and their industry partners have unveiled a world first: the prototype of a robot-controlled, high-speed combined charging system (CCS) for electric vehicles that enables series charging of cars in various parking positions.

Global demand for electric vehicles is forecast to rise sharply: by 2025, the number of new vehicle registrations is expected to reach 25 million per year....

Im Focus: The “TRiC” to folding actin

Proteins must be folded correctly to fulfill their molecular functions in cells. Molecular assistants called chaperones help proteins exploit their inbuilt folding potential and reach the correct three-dimensional structure. Researchers at the Max Planck Institute of Biochemistry (MPIB) have demonstrated that actin, the most abundant protein in higher developed cells, does not have the inbuilt potential to fold and instead requires special assistance to fold into its active state. The chaperone TRiC uses a previously undescribed mechanism to perform actin folding. The study was recently published in the journal Cell.

Actin is the most abundant protein in highly developed cells and has diverse functions in processes like cell stabilization, cell division and muscle...

All Focus news of the innovation-report >>>

Anzeige

Anzeige

VideoLinks
Industry & Economy
Event News

LaserForum 2018 deals with 3D production of components

17.08.2018 | Event News

Within reach of the Universe

08.08.2018 | Event News

A journey through the history of microscopy – new exhibition opens at the MDC

27.07.2018 | Event News

 
Latest News

Smallest transistor worldwide switches current with a single atom in solid electrolyte

17.08.2018 | Physics and Astronomy

Robots as Tools and Partners in Rehabilitation

17.08.2018 | Information Technology

Climate Impact Research in Hannover: Small Plants against Large Waves

17.08.2018 | Life Sciences

VideoLinks
Science & Research
Overview of more VideoLinks >>>